Specnuezhenide reduces carbon tetrachloride-induced liver injury in mice through inhibition of oxidative stress and hepatocyte apoptosis.
Dongmei HuShaojie HuangYi DingXian ZhaoWei ZhangHaixia ChenJing-Wen WangPublished in: The Journal of pharmacy and pharmacology (2022)
Specnuezhenide reduced CCl4-induced liver injury in mice by inhibiting oxidative stress via activation of Nrf2 signalling and decreasing hepatocyte apoptosis.